101 related articles for article (PubMed ID: 19562840)
1. [Analysis of the metabolome suggests a major potential role of sarcosine in the progression of cancer of the prostate].
Darbon JM
Bull Cancer; 2009 Apr; 96(4):355-6. PubMed ID: 19562840
[No Abstract] [Full Text] [Related]
2. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
Sreekumar A; Poisson LM; Rajendiran TM; Khan AP; Cao Q; Yu J; Laxman B; Mehra R; Lonigro RJ; Li Y; Nyati MK; Ahsan A; Kalyana-Sundaram S; Han B; Cao X; Byun J; Omenn GS; Ghosh D; Pennathur S; Alexander DC; Berger A; Shuster JR; Wei JT; Varambally S; Beecher C; Chinnaiyan AM
Nature; 2009 Feb; 457(7231):910-4. PubMed ID: 19212411
[TBL] [Abstract][Full Text] [Related]
4. Sarcosine as a potential prostate cancer biomarker--a review.
Cernei N; Heger Z; Gumulec J; Zitka O; Masarik M; Babula P; Eckschlager T; Stiborova M; Kizek R; Adam V
Int J Mol Sci; 2013 Jul; 14(7):13893-908. PubMed ID: 23880848
[TBL] [Abstract][Full Text] [Related]
5. Is sarcosine a biomarker for prostate cancer?
Issaq HJ; Veenstra TD
J Sep Sci; 2011 Dec; 34(24):3619-21. PubMed ID: 22009695
[TBL] [Abstract][Full Text] [Related]
6. Re: expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. T. Kurahashi, H. Miyake, I. Hara and M. Fujisawa J Urol 2007; 177: 757-761.
Vale S
J Urol; 2007 Jul; 178(1):352-3. PubMed ID: 17507039
[No Abstract] [Full Text] [Related]
7. Characterization of osmolyte betaine synthesizing sarcosine dimethylglycine N-methyltransferase from Methanohalophilus portucalensis.
Chen SY; Lai MC; Lai SJ; Lee YC
Arch Microbiol; 2009 Oct; 191(10):735-43. PubMed ID: 19693490
[TBL] [Abstract][Full Text] [Related]
8. Effects of substrate and potassium on the betaine-synthesizing enzyme glycine sarcosine dimethylglycine N-methyltransferase from a halophilic methanoarchaeon Methanohalophilus portucalensis.
Lai MC; Wang CC; Chuang MJ; Wu YC; Lee YC
Res Microbiol; 2006 Dec; 157(10):948-55. PubMed ID: 17098399
[TBL] [Abstract][Full Text] [Related]
9. Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer.
Heger Z; Merlos Rodrigo MA; Michalek P; Polanska H; Masarik M; Vit V; Plevova M; Pacik D; Eckschlager T; Stiborova M; Adam V
PLoS One; 2016; 11(11):e0165830. PubMed ID: 27824899
[TBL] [Abstract][Full Text] [Related]
10. The role of sarcosine metabolism in prostate cancer progression.
Khan AP; Rajendiran TM; Ateeq B; Asangani IA; Athanikar JN; Yocum AK; Mehra R; Siddiqui J; Palapattu G; Wei JT; Michailidis G; Sreekumar A; Chinnaiyan AM
Neoplasia; 2013 May; 15(5):491-501. PubMed ID: 23633921
[TBL] [Abstract][Full Text] [Related]
11. TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
Green T; Chen X; Ryan S; Asch AS; Ruiz-EchevarrÃa MJ
Prostate; 2013 Oct; 73(14):1561-75. PubMed ID: 23824605
[TBL] [Abstract][Full Text] [Related]
12. [New approaches to molecular diagnosis of prostatic cancer].
Kovalev LI; Shishkin SS; Khasigov PZ; Dzeranov NK; Kazachenko AV; Kovaleva MA; Toropygin IIu; Eremina LS; Grachev SV
Urologiia; 2006; (5):16-9. PubMed ID: 17444146
[TBL] [Abstract][Full Text] [Related]
13. Sarcosine influences apoptosis and growth of prostate cells via cell-type specific regulation of distinct sets of genes.
Rodrigo MAM; Strmiska V; Horackova E; Buchtelova H; Michalek P; Stiborova M; Eckschlager T; Adam V; Heger Z
Prostate; 2018 Feb; 78(2):104-112. PubMed ID: 29105933
[TBL] [Abstract][Full Text] [Related]
14. Sarcosine, folate metabolism and prostate cancer--is there a link?
Wagner C; Luka Z
J Urol; 2011 Feb; 185(2):385-6. PubMed ID: 21168165
[No Abstract] [Full Text] [Related]
15. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
[TBL] [Abstract][Full Text] [Related]
16. [Intraprostatic neuroendocrine system and glandular carcinogenesis].
Moretti C; Mencacci C; Frajese V; Frajese G
Recenti Prog Med; 2000 Nov; 91(11):571-5. PubMed ID: 11125950
[No Abstract] [Full Text] [Related]
17. Diagnostics: The prostate-cancer metabolome.
Abate-Shen C; Shen MM
Nature; 2009 Feb; 457(7231):799-800. PubMed ID: 19212391
[No Abstract] [Full Text] [Related]
18. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach.
Qingyi Z; Lin Y; Junhong W; Jian S; Weizhou H; Long M; Zeyu S; Xiaojian G
Cancer Invest; 2009 Aug; 27(7):794-801. PubMed ID: 19637042
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Enzymatic Traits between Native and Recombinant Glycine Sarcosine N-Methyltransferase from Methanohalophilus portucalensis FDF1T.
Lai SJ; Deng YC; Lai MC
PLoS One; 2016; 11(12):e0168666. PubMed ID: 28036340
[TBL] [Abstract][Full Text] [Related]
20. Sarcosine as a potential prostate cancer biomarker and therapeutic target.
Baum CE; Price DK; Figg WD
Cancer Biol Ther; 2010 Mar; 9(5):341-2. PubMed ID: 20150759
[No Abstract] [Full Text] [Related]
[Next] [New Search]
